Find your next paid study

Spaulding Rehabilitation HospitalNCT07709559

~$10 – $750

Phase 1

A Phase 1/2a, Open-Label, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX319 in Subjects With Primary or Secondary Progressive Multiple Sclerosis

The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called primary progressive or secondary prog…

Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple Sclerosis+2 more

~$10 – $8,750

Tr1X, Inc.NCT07477639

Posttraumatic Stress DisorderAnger

A Randomized Controlled Trial of the Mobile Anger Reduction Intervention for Veterans

Difficulty controlling anger is the most commonly reported reintegration concern among combat Veterans, especially those with a diagnosis of posttraumatic stre…

VA Office of Research and DevelopmentNCT06094933

~$10 – $5,625

Mental Health IssueAnxiety DisorderDepressive Disorder+1 more

Unified Protocol: Community Connections

The purpose of this study is to administer the Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) and Adolescents (UP-A)…

University of MiamiNCT06038721

NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)

Background: Gulf War illness (GWI) affects up to 210,000 U.S. veterans who served in the Middle East during the Gulf War in 1990-1991. Symptoms include fatigu…

Gulf War Illness

National Institute of Neurological Disorders and Stroke (NINDS)NCT05375812

~$10 – $675

Phase 1

TulmiSTAR-01: A Two-part, Phase I Dose Escalation and Expansion Followed by a Randomized, Open-label Multicenter, Phase II Study to Assess the Safety and Efficacy of the Combination of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) vs Standard of Care in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462…

Progressive Metastatic Castrate Resistant Prostate Cancer

Novartis PharmaceuticalsNCT07206056

~$10 – $8,750

Phase 4

A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VM…

SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more

Neurocrine BiosciencesNCT07105111

~$10 – $8,750

Traumatic Brain InjuryStrokeBrain Disease+4 more

Chronic Stimulation of the Motor Ventral Thalamus (VOP/VIM) for Motor Control in Humans

This study aims to recruit patients already implanted with Deep Brain Stimulation (DBS) for movement disorders to complete tasks assessing parameters of motor …

Jorge Gonzalez-MartinezNCT07056348

~$10 – $7,500

SmokingSmoking CessationPhysical Inactivity

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) amo…

University of RochesterNCT06926608

Post-traumatic Brain Injury DepressionVeteran Health

Development of Low-Intensity Focused Ultrasound for Post Traumatic Brain Injury Depression

The goal of this clinical trial is to learn about evaluate the safety, tolerability, and feasibility of MRI-guided LIFU targeting the sgACC in Veterans with po…

Stanford UniversityNCT07828483

Perinatal DepressionPost Partum DepressionMajor Depressive Disorder

Perinatal Accelerated iTBS Neuromodulation Therapy

We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal…

Brigham and Women's HospitalNCT06968390

Phase 2

A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia

This phase II trial studies the side effects and how well fludarabine phosphate, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin hydrochlori…

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1+7 more